Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

I this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interviews will be conducted by the UNC CHAI Core and will continue until thematic saturation (estimated 10 participants). The investigators will code the qualitative data using emerging themes, guided by a well-established implementation science theory, the Consolidated Framework for Implementation Research (CFIR). The information gained from these studies will inform an implementation approach to increase the usability and acceptability of a novel prognostic tool to assist oncologists in the prognosis of patients with metastatic breast cancer.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• Verbal informed consent obtained to participate in the study.

• Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.

• Physician, nurse practitioner, physician assistant, or nurse navigator

• At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.

Locations
United States
North Carolina
University of North Carolina
RECRUITING
Chapel Hill
Contact Information
Primary
Terri Eubanks, BSBA
teubanks@med.unc.edu
919-966-4530
Backup
Erin Kelly, MPH, RD, LDN
erin_kelly@med.unc.edu
919-966-0040
Time Frame
Start Date: 2022-07-07
Estimated Completion Date: 2027-08-10
Participants
Target number of participants: 15
Treatments
Clinicans
Participants will include: physicians, nurse practitioners, physician assistants, and nurse navigators. Participants will be recruited from the UNC Medical Center breast oncology group as well as other practices identified by the Principal Investigator based on existing professional networks (referring physicians, other UNC oncology entities, collaborative groups).
Related Therapeutic Areas
Sponsors
Collaborators: Conquer Cancer Foundation
Leads: UNC Lineberger Comprehensive Cancer Center

This content was sourced from clinicaltrials.gov